<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29718" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Superior Vena Cava Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Seligson</surname>
            <given-names>Marc T.</given-names>
          </name>
          <aff>SUNY Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Surowiec</surname>
            <given-names>Scott M.</given-names>
          </name>
          <aff>Upstate Medical University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marc Seligson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Scott Surowiec declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>26</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29718.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Superior vena cava (SVC) syndrome is a collection of clinical signs and symptoms resulting from partial or complete obstruction of blood flow through the SVC. This obstruction is most commonly a result of thrombus formation or tumor infiltration of the vessel wall. The superior vena cava is formed by the junction of the left and right innominate (brachiocephalic) veins and is tasked with returning blood from the head, neck, upper extremities, and torso to the heart. Today, this syndrome is most commonly seen secondary to malignancy, although there has been a more recent rise in benign etiologies. This activity describes the causes, pathophysiology, and presentation of superior vena cava syndrome and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Evaluate&#x000a0;the causes of superior vena cava syndrome.</p></list-item><list-item><p>Identify the pathophysiology of superior vena cava syndrome.</p></list-item><list-item><p>Assess&#x000a0;the treatment options for superior vena cava syndrome.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by superior vena cava syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29718&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29718">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29718.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Superior vena cava (SVC) syndrome is a collection of clinical signs and symptoms resulting from partial or complete obstruction of blood flow through the SVC. This obstruction is most commonly a result of thrombus formation or tumor infiltration of the vessel wall. The SVC&#x000a0;is formed by the junction of the left and right innominate (brachiocephalic) veins and is tasked with returning blood from the head, neck, upper extremities, and torso back to the heart (see <bold>Image.</bold> Veins and Arteries of the Neck). Today, this syndr&#x00192;ome is most commonly seen secondary to malignancy, although there has been a recent rise in benign etiologies. The resulting venous congestion produces a clinical scenario of increased upper-body venous pressure. The most common signs and symptoms include face or neck swelling, upper extremity swelling, dyspnea, cough, and dilated chest vein collaterals.<xref ref-type="bibr" rid="article-29718.r1">[1]</xref><xref ref-type="bibr" rid="article-29718.r2">[2]</xref><xref ref-type="bibr" rid="article-29718.r3">[3]</xref></p>
      </sec>
      <sec id="article-29718.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>SVC syndrome saw a dramatic decrease throughout the twentieth century. Today, the majority of SVC syndromes are the result of mediastinal malignancies, primarily among which are small-cell bronchogenic carcinoma. The second most commonly associated malignancy is&#x000a0;non-Hodgkins lymphoma, followed by metastatic tumors. In addition, benign or nonmalignant causes of&#x000a0;SVC syndrome now comprise at least 40% of cases. Iatrogenic thrombus formation or SVC stenosis is a growing etiology due to pacemaker wires and semipermanent intravascular catheters used for hemodialysis, long-term antibiotics, or chemotherapy.<xref ref-type="bibr" rid="article-29718.r4">[4]</xref><xref ref-type="bibr" rid="article-29718.r5">[5]</xref></p>
      </sec>
      <sec id="article-29718.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>An estimated 15,000 cases of SVC&#x000a0;syndrome occur each year in the United States, with studies pointing to increasing frequency due to the concomitant rise in the use of semipermanent intravascular catheters. The incidence of SVC syndrome reported in the literature ranges from 1 in 650 to 1 in 3100 patients.</p>
      </sec>
      <sec id="article-29718.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The SVC is part of the low-pressure venous system containing thin walls susceptible to damage by various pathologic mechanisms. These mechanisms can be divided into&#x000a0;3 categories: compromised vessel anatomy, impaired venous flow, and diminished vessel wall integrity. These mechanisms often coexist in patients presenting with SVC syndrome. Extrinsic compression and obstruction of the SVC by a mass in the mediastinum is the most common cause of SVC syndrome. This is often associated with malignancy; however, a variety of nonmalignant masses and dilation of the overlying aorta can cause compression. A growing proportion of SVC syndromes are now associated with occlusive venous thrombus formation that compromises venous flow back to the heart. The increasing use of indwelling intravascular devices such as catheters, pacemakers, and implantable cardioverter-defibrillator (ICD) leads to this growth. Resultant venous wall inflammation, fibrosis, and eventual thrombus lead to vessel stenosis.<xref ref-type="bibr" rid="article-29718.r6">[6]</xref><xref ref-type="bibr" rid="article-29718.r7">[7]</xref><xref ref-type="bibr" rid="article-29718.r8">[8]</xref></p>
      </sec>
      <sec id="article-29718.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>SVC syndrome diagnosis is largely based on a patient&#x02019;s history and physical findings, which often develop over days to weeks. This insidious onset results from a collateral vascular network that diverts blood to the lower body, where it is then returned to the heart through the inferior vena cava, azygos vein, and intercostals. The clinical findings in SVC syndrome are closely linked to venous congestion and the resultant elevation in venous pressures seen in the upper body. A careful physical examination is often sufficient to rule out a cardiogenic origin of the patient&#x02019;s symptoms. The most common presenting symptoms of SVC syndrome are face/neck swelling, distended neck veins, cough, dyspnea, orthopnea, upper extremity swelling, distended chest vein collaterals, and conjunctival suffusion. Other less common symptoms of SVC syndrome include stridor, hoarseness, dysphagia, pleural effusion, head plethora, headache, nausea, lightheadedness, syncope, change in vision, altered mental status, upper body edema, cyanosis, papilledema, stupor, and coma. Some rare but serious clinical consequences reported in SVC syndrome include cerebral edema and upper respiratory compromise secondary to edema of the larynx and pharynx.</p>
      </sec>
      <sec id="article-29718.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Patients with high clinical suspicion for SVC syndrome should undergo imaging of the upper body and vasculature. Ultrasound of the jugular, subclavian, and innominate veins can help to identify a thrombus within the vessel lumen. Radiographic imaging and MRI also play a critical role in providing additional information about the SVC obstruction's location, severity, and etiology. CT of the chest with collateral vessels is associated with a diagnostic sensitivity of 96% and a specificity of 92%. Venography is widely accepted as the gold standard for visualizing and diagnosing a venous obstruction. This modality should be used concomitantly with endovascular intervention for patients with a severe presentation of SVC syndrome.<xref ref-type="bibr" rid="article-29718.r9">[9]</xref><xref ref-type="bibr" rid="article-29718.r10">[10]</xref></p>
      </sec>
      <sec id="article-29718.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Following a clinical diagnosis, supportive therapy and medical management are commonly initiated. This involves elevating the patient&#x02019;s head as a simple maneuver to decrease venous pressure. Further management is guided by the patient&#x02019;s underlying SVC syndrome etiology. For patients with thrombus related to an indwelling intravascular device, removal should be considered along with anticoagulation therapy and catheter-directed thrombolysis. Multidisciplinary treatment planning for those with obstruction due to malignancy is important as tumor type and staging can help to guide appropriate chemotherapy or radiation therapy. Open surgical repair through bypass grafting with spiral saphenous vein, femoral vein, polytetrafluoroethylene (PTFE) graft, or Dacron graft has traditionally been considered to overcome SVC obstruction. However, this is now reserved for cases where recanalization through endovascular repair is either impossible or has previously failed. With expanding treatment options for both benign and malignant etiology, endovascular therapy is now widely considered the first-line treatment for SVC syndrome. Less invasive endovascular management can offer patients immediate relief of symptoms. Acute or subacute thrombus can be managed with catheter-based thrombolysis or thrombectomy before venoplasty and stent placement.<xref ref-type="bibr" rid="article-29718.r11">[11]</xref><xref ref-type="bibr" rid="article-29718.r12">[12]</xref><xref ref-type="bibr" rid="article-29718.r13">[13]</xref></p>
      </sec>
      <sec id="article-29718.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for superior vena cava syndrome includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac tamponade</p>
          </list-item>
          <list-item>
            <p>Mediastinitis</p>
          </list-item>
          <list-item>
            <p>Thoracic aortic aneurysm</p>
          </list-item>
          <list-item>
            <p>Tuberculosis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29718.s10" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p> A widely accepted and standardized set of criteria outlining presentation severity does not exist for SVC syndrome. The Kishi Scoring System for Signs and Symptoms of SVC syndrome grades severity based on the patient&#x02019;s clinical presentation. This scoring system includes&#x000a0;the patient&#x02019;s neurologic symptoms, laryngopharyngeal or thoracic symptoms, nasal and facial signs or symptoms, and the presence of venous dilatation.</p>
      </sec>
      <sec id="article-29718.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Because there are many causes of SVCS, the condition is best managed by an&#x000a0;interprofessional&#x000a0;team of healthcare workers, including a vascular surgeon, interventional radiologist, radiation&#x000a0;therapist, oncologist, pain specialist, and cardiac surgeon. The nurse plays a vital role in the monitoring of these patients. Many of them have cerebral&#x000a0;and laryngeal edema and need close monitoring. The pharmacist should be fully aware of the drugs used to manage SVCS, which include corticosteroids and diuretics. Because many of these patients have an unpredictable&#x000a0;course, radiation is often administered as a palliative&#x000a0;measure to shrink the tumor and relieve the symptoms. Patients with Hodgkin lymphoma are managed with chemotherapy.<xref ref-type="bibr" rid="article-29718.r14">[14]</xref><xref ref-type="bibr" rid="article-29718.r15">[15]</xref></p>
        <p>
<bold>Outcomes</bold>
</p>
        <p>The prognosis&#x000a0;of patients with SVCS depends on the cause. For patients with a benign cause of SVCS, the life expectancy is not changed, but for malignant cases, there is a significant drop in survival. Individuals who have features of cerebral and laryngeal edema can develop life-threatening&#x000a0;symptoms and suddenly die. Patients with SVCS as a result of lung cancer usually&#x000a0;live less than 24 months. For those who do not respond&#x000a0;to radiation treatment, the survival is less than a year.<xref ref-type="bibr" rid="article-29718.r16">[16]</xref><xref ref-type="bibr" rid="article-29718.r17">[17]</xref><xref ref-type="bibr" rid="article-29718.r18">[18]</xref></p>
      </sec>
      <sec id="article-29718.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29718&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29718">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/superior-vena-cava-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29718">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29718/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29718">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29718.s13">
        <fig id="article-29718.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Veins and Arteries of the Neck. Superior vena cava, left and right innominate vein, left and right subclavian vein, left and right internal jugular vein, innominate arteries, hyoid bone, thyroid gland, and trachea. Henry Vandyke Carter, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/wiki/File:Gray_%E2%80%94_musculus_levator_glandulae_thyroideae.png">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Gray560" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29718.s14">
        <title>References</title>
        <ref id="article-29718.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drouin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pistorius</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Lafforgue</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>N'Gohou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Connault</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Espitia</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>[Upper-extremity venous thrombosis: A retrospective study about 160&#x000a0;cases].</article-title>
            <source>Rev Med Interne</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-15</page-range>
            <pub-id pub-id-type="pmid">30122260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmerman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Rapid Fire: Superior Vena Cava Syndrome.</article-title>
            <source>Emerg Med Clin North Am</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>577</fpage>
            <page-range>577-584</page-range>
            <pub-id pub-id-type="pmid">30037444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carmo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chronic Occlusion of the Superior Vena Cava.</article-title>
            <source>N Engl J Med</source>
            <year>2018</year>
            <month>Jul</month>
            <day>05</day>
            <volume>379</volume>
            <issue>1</issue>
            <fpage>e2</fpage>
            <pub-id pub-id-type="pmid">29972752</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Potter</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Huyskens</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hiddinga</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Spinhoven</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Meerbeeck</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Parizel</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Snoeckx</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Imaging of urgencies and emergencies in the lung cancer patient.</article-title>
            <source>Insights Imaging</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>463</fpage>
            <page-range>463-476</page-range>
            <pub-id pub-id-type="pmid">29644546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedman</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Quencer</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Kishore</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Winokur</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Madoff</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond.</article-title>
            <source>Semin Intervent Radiol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>398</fpage>
            <page-range>398-408</page-range>
            <pub-id pub-id-type="pmid">29249864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalinin</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Suchkov</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Shitov</surname>
                <given-names>II</given-names>
              </name>
              <name>
                <surname>Mzhavanadze</surname>
                <given-names>ND</given-names>
              </name>
              <name>
                <surname>Povarov</surname>
                <given-names>VO</given-names>
              </name>
            </person-group>
            <article-title>[Venous thromboembolic complications in patients with cardiovascular implantable electronic devices].</article-title>
            <source>Angiol Sosud Khir</source>
            <year>2017</year>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>69</fpage>
            <page-range>69-74</page-range>
            <pub-id pub-id-type="pmid">29240058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghorbani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vakili Sadeghi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hejazian</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sharbatdaran</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Superior vena cava syndrome as a paraneoplastic manifestation of soft tissue sarcoma.</article-title>
            <source>Hematol Transfus Cell Ther</source>
            <year>2018</year>
            <season>Jan-Mar</season>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>75</fpage>
            <page-range>75-78</page-range>
            <pub-id pub-id-type="pmid">30057975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Labriola</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Seront</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Crott</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borceux</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jadoul</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Superior vena cava stenosis in haemodialysis patients with a tunnelled cuffed catheter: prevalence and risk factors.</article-title>
            <source>Nephrol Dial Transplant</source>
            <year>2018</year>
            <month>Dec</month>
            <day>01</day>
            <volume>33</volume>
            <issue>12</issue>
            <fpage>2227</fpage>
            <page-range>2227-2233</page-range>
            <pub-id pub-id-type="pmid">29893920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mansour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saadeh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Abdel-Razeq</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Khozouz</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Abunasser</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taqash</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical Course and Complications of Catheter and Non-Catheter-Related Upper Extremity Deep Vein Thrombosis in Patients with Cancer.</article-title>
            <source>Clin Appl Thromb Hemost</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>1234</fpage>
            <page-range>1234-1240</page-range>
            <pub-id pub-id-type="pmid">30025472</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>UA</given-names>
              </name>
              <name>
                <surname>Shanholtz</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>McCurdy</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Oncologic Mechanical Emergencies.</article-title>
            <source>Hematol Oncol Clin North Am</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>927</fpage>
            <page-range>927-940</page-range>
            <pub-id pub-id-type="pmid">29078930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nossair</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schoettler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Starr</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AKC</given-names>
              </name>
              <name>
                <surname>Kirov</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Paes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mahajerin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature.</article-title>
            <source>Pediatr Blood Cancer</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>65</volume>
            <issue>9</issue>
            <fpage>e27225</fpage>
            <pub-id pub-id-type="pmid">29781569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ierardi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Jannone</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Petrillo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brambillasca</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Fumarola</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Angileri</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Crippa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Carrafiello</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of venous stenosis in oncologic patients.</article-title>
            <source>Future Oncol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>28</issue>
            <fpage>2933</fpage>
            <page-range>2933-2943</page-range>
            <pub-id pub-id-type="pmid">29623736</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gloviczki</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Endovenous and Operative Treatment of Superior Vena Cava Syndrome.</article-title>
            <source>Surg Clin North Am</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>98</volume>
            <issue>2</issue>
            <fpage>321</fpage>
            <page-range>321-335</page-range>
            <pub-id pub-id-type="pmid">29502774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hague</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tippett</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Endovascular techniques in palliative care.</article-title>
            <source>Clin Oncol (R Coll Radiol)</source>
            <year>2010</year>
            <month>Nov</month>
            <volume>22</volume>
            <issue>9</issue>
            <fpage>771</fpage>
            <page-range>771-80</page-range>
            <pub-id pub-id-type="pmid">20833516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gradishar</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Magid</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bitran</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Supportive care of the lung cancer patients.</article-title>
            <source>Hematol Oncol Clin North Am</source>
            <year>1990</year>
            <month>Dec</month>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>1183</fpage>
            <page-range>1183-99</page-range>
            <pub-id pub-id-type="pmid">1704881</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lianos</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Hasemaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tzima</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vangelis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tselios</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mpailis</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lekkas</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Superior vena cava syndrome due to central port catheter thrombosis: a real life-threatening condition.</article-title>
            <source>G Chir</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-106</page-range>
            <pub-id pub-id-type="pmid">29694310</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuo</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Endovascular stenting for end-stage lung cancer patients with superior vena cava syndrome post first-line treatments - A single-center experience and literature review.</article-title>
            <source>J Chin Med Assoc</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>80</volume>
            <issue>8</issue>
            <fpage>482</fpage>
            <page-range>482-486</page-range>
            <pub-id pub-id-type="pmid">28501315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29718.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakano</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Endo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kanai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsubochi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tetsuka</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Surgical outcomes after superior vena cava reconstruction with expanded polytetrafluoroethylene grafts.</article-title>
            <source>Ann Thorac Cardiovasc Surg</source>
            <year>2014</year>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>310</fpage>
            <page-range>310-5</page-range>
            <pub-id pub-id-type="pmid">23801179</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
